Harnessing Disruptive CAR & TCR Based Cell Technologies to Supercharge Safe, Effective & Globally Accessible Cell Immunotherapies in Oncology & Beyond
The 6th Annual CAR-TCR Summit returns in 2021 as the industry-leading comprehensive forum with one goal: to engineer a disease-free world.
As the industry reaches an inflection point and CAR-TCR therapies enter the commercial setting at increasing velocity, now is the time to join with all the key stakeholders to share strategies from early phase development to market access and commercial readiness. Gain end-to-end insights from established thought leaders, and the innovators bringing disruptive technologies from bench to bedside, and from vein to vein.
Across 4 days of carefully curated sessions, we will gather with 150+ CAR and TCR cell therapy VIPs that will lead you in discussions from commercial pipeline development to the ground-breaking approaches being pioneered by the next generation of leaders.
Explore iPSC-derived constructs, novel allogeneic approaches, supercharging therapies against solid tumor indications and integrate automation and streamlined manufacturing for consistency at scale, with
reduced cost of goods.
You can’t afford to miss the 6th Annual CAR-TCR Summit as we bring you more speakers, more content and more exclusive insights than ever before!
A Snapshot of the 150+ Leading Speakers Bringing Innovation & Insights from Discovery to Market Access
Chief Scientific Officer
Senti Biosciences Inc.
Alliance for Regenerative Medicine
Director - Biologics Evaluation & Research
US Food & Drug Administration (FDA)
President, Co-Founder & Chief Executive Officer
Executive Director & Global Head of Quality Control
Kite Pharma Inc
Senior Vice President & Head of Therapeutic Area Oncology, Research, Development & Governance Chair
Executive Director - Global Patient Operations
Bristol-Myers Squibb Co.
President & Chief Executive Officer
Director, Cellular Therapeutics
Memorial Sloan Kettering Cancer Center
Global Head of Cell & Gene